临床试验 10
- 177 Lu-rhPSMA-10.1注射液在mCRPC中显示出阳性辐射剂量测定结果
- FDA授予Detalimogene vorapplant用于高风险NMIBC的RMAT认证
- Anne Schuckman医学博士强调了NMIBC有前途的新发展
- Phase 3 trial launches of ifinatamab deruxtecan vs chemotherapy in mCRPC
- 在mCRPC中启动伊非那他玛德鲁克替康与化疗的3期试验
- FDA approves integrated sacral neuromodulation system for urinary urge incontinence
- Khurshid Ghani，MBChB，MS，FRCS，谈当前支架遗漏的障碍
- 不同mHSPC人群中剩余未满足的需求
- Improving diversity in future clinical trials for mHSPC
- FDA批准Anktiva扩大使用计划治疗淋巴细胞减少症